Oxbow Advisors LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 29,637 shares of the company’s stock, valued at approximately $2,694,000.
Other hedge funds have also recently bought and sold shares of the company. Centricity Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $27,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $32,000. Hager Investment Management Services LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $36,000. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $42,000. Finally, Roxbury Financial LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $43,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive Price Performance
NYSE:CL opened at $89.56 on Friday. Colgate-Palmolive has a one year low of $84.45 and a one year high of $109.30. The company has a market cap of $72.68 billion, a P/E ratio of 25.44, a P/E/G ratio of 4.18 and a beta of 0.44. The firm’s fifty day moving average price is $88.94 and its two-hundred day moving average price is $95.91. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Analysts Set New Price Targets
A number of analysts have recently commented on CL shares. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Finally, Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $101.16.
Check Out Our Latest Report on CL
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Options Trading – Understanding Strike Price
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Invest in the FAANG Stocks
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.